KRAS G12C MUTATION
Clinical trials for KRAS G12C MUTATION explained in plain language.
Never miss a new study
Get alerted when new KRAS G12C MUTATION trials appear
Sign up with your email to follow new studies for KRAS G12C MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized medicine takes on brain tumors: Gene-Targeted drugs show promise
Disease control OngoingThis study tests whether genetic testing can help doctors choose the right drug for people whose cancer has spread to the brain. Researchers will look for specific gene changes in tumor samples and then give patients a targeted medication matched to their mutation. The goal is to…
Matched conditions: KRAS G12C MUTATION
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Scientists dig into genetic secrets of Drug-Resistant lung cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers stop responding to targeted therapy (tyrosine kinase inhibitors). Researchers will analyze tumor tissue from 40 patients to find hidden genetic changes that cause drug resistance. The goal is to uncover new ways to treat these resistan…
Matched conditions: KRAS G12C MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC